Investing

Equal-weight S&P 500 is leading the 2026 market and its flagship trade just hit $100 billion

The atmosphere at the New York Stock Exchange was electric on April 15, 2026, as traders celebrated a historic milestone with the S&P 500 closing above the 7,000 level for the first time. However, beneath the surface of this record breaking rally, a significant shift in investor behavior is taking place. While traditional market weighted indexes have long been dominated by a handful of tech giants, investors are now flocking to equal weight strategies to avoid putting too many eggs in one basket.

This trend has propelled the Invesco S&P 500 Equal Weight ETF, known as RSP, into a new league of success. By giving every company in the index an identical share regardless of size, RSP has allowed investors to pivot away from the concentration risk associated with the Magnificent Seven. These mega cap technology firms once drove almost all market gains but have cooled off in early 2026 as massive AI capital expenditures began to weigh on sentiment. Consequently, RSP has outperformed its market weighted counterparts by roughly 3 percent through late August and seen its assets under management surge past $100 billion for the first time.

Industry experts suggest that this move represents a long overdue diversification play. Nathan Geraci, president of NovaDius, notes that because the top ten names often account for nearly 40 percent of standard indices, any stumble by a few AI leaders can drag down an entire portfolio. With earnings growth strengthening across the remaining 493 companies in the S&P 500, equal weighting provides a way to bet on all horses rather than trying to pick a single winner in an overpriced sector.

While behemoth funds like those from Vanguard and BlackRock still command trillions of dollars in total assets, the rise of smart beta and equal weight tools indicates a maturing appetite for balance. Beyond the flagship RSP fund, investors are exploring niche equal weight options spanning everything from biotechnology to materials. Whether used as a tactical short term trade or a permanent defensive posture, these funds are proving that there is plenty of life and profit left outside of Silicon Valley’s biggest players.